Genetic Signatures Share Price and Company Fundamentals

0.020 (1.923%)
52 week
0.94 - 1.86

Last traded: Today at 2:53 AM

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, Asia Pacific, North America, Europe, the Middle East, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory pathogens, sexual health, anti-microbial resistance, meningitis, and tropical disease. The company was incorporated in 2001 and is headquartered in Newtown, Australia.

Key Metrics

PE ratio


PB ratio


Dividend yield




Market cap


Enterprise value


Company profile

Primary activitiesMolecular Diagnostics.
Industry / SectorDiagnostics & Research / Healthcare
Mailing address7 Eliza Street Newtown NSW 2042 Australia
Phone / Fax61 2 9870 7580 /


More: Genetic Signatures Dividend history, yield and payout ratio

Dividend yield


Dividend amount


Payout ratio


Genetic Signatures paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.GSS dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

GSS's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Aug 2022, following are the company executives and directors listed on Genetic Signatures.

NameTitleAgeTotal Pay
Dr. John R. Melki BSc, Ph.D.MD, CEO & Exec. Director483.01k
Mr. Peter L. Manley CPACFO & Company Sec.285.37k
Mr. Michael Anton Aicher BSc, M.B.A., MBAExec. Director of US Operations & Exec. Director61161.55k
Mr. Christopher M. AbbottFounder & Chairman Emeritus
Dr. Douglas S. Millar BSc, Ph.D.Chief Scientific Officer
Mr. Jackson Jones B.Sc.Director of Global Sales & Marketing

Profitability and management effectiveness

Profit margin


Operating margin


Return on assets


Return on equity


Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Genetic Signatures is and its enterprise value is .

Companies similar to Genetic Signatures (GSS)

Genetic Signatures (ASX:GSS) Frequently Asked Questions

1. What is Genetic Signatures's Stock Symbol?

Genetic Signatures trades on ASX under the ticker symbol "GSS".

2. What is Genetic Signatures's stock price today?

One share of GSS stock can currently be purchased for approximately $1.06.

3. How can I contact Genetic Signatures?

Genetic Signatures's mailing address is 7 Eliza Street Newtown NSW 2042 Australia. The company can be reached via phone at 61 2 9870 7580.

4. What is Genetic Signatures's official website?

The official website of Genetic Signatures is

5. Which share registry manages Genetic Signatures's stock?

Genetic Signatures's stock is managed by BOARDROOM PTY LIMITED.